Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Raue

Showing results (201-210 of 215) with videos related to

Pageof 22
Sort By:
Oncogene|February 18, 1999
Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutationO Gimm, D S Neuberg, D J Marsh, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1993
Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative studyU Dörr, S Würstlin, K Frank-Raue, et al.
International Journal of Cancer|March 10, 2001
Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinomaT Schilling, J Bürck, H P Sinn, et al.
Deutsche Medizinische Wochenschrift (1946)|September 26, 2003
[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization]K Frank-Raue, C Heimbach, S Rondot, et al.
Clinical Endocrinology|July 1, 1995
Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinomaC Eng, L M Mulligan, D P Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potentialT M Behr, M Béhé, C Angerstein, et al.
Cancer Research|December 11, 1997
Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor typeT M Behr, E Wulst, S Radetzky, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 18, 2006
Late diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiencyK Müssig, S Kaltenbach, C Maser-Gluth, et al.
Genes, Chromosomes & Cancer|March 1, 1995
Mutation of the RET protooncogene in sporadic medullary thyroid carcinomaC Eng, L M Mulligan, D P Smith, et al.
Archives of Internal Medicine|June 1, 1992
The natural course of multiple endocrine neoplasia type IIb. A study of 18 casesH F Vasen, M van der Feltz, F Raue, et al.
Pageof 22

Showing results (201-210 of 215) with videos related to

Sort By:
Pageof 22
Oncogene|February 18, 1999
Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutationO Gimm, D S Neuberg, D J Marsh, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1993
Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative studyU Dörr, S Würstlin, K Frank-Raue, et al.
International Journal of Cancer|March 10, 2001
Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinomaT Schilling, J Bürck, H P Sinn, et al.
Deutsche Medizinische Wochenschrift (1946)|September 26, 2003
[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization]K Frank-Raue, C Heimbach, S Rondot, et al.
Clinical Endocrinology|July 1, 1995
Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinomaC Eng, L M Mulligan, D P Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potentialT M Behr, M Béhé, C Angerstein, et al.
Cancer Research|December 11, 1997
Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor typeT M Behr, E Wulst, S Radetzky, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 18, 2006
Late diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiencyK Müssig, S Kaltenbach, C Maser-Gluth, et al.
Genes, Chromosomes & Cancer|March 1, 1995
Mutation of the RET protooncogene in sporadic medullary thyroid carcinomaC Eng, L M Mulligan, D P Smith, et al.
Archives of Internal Medicine|June 1, 1992
The natural course of multiple endocrine neoplasia type IIb. A study of 18 casesH F Vasen, M van der Feltz, F Raue, et al.
Pageof 22